IRIS
GEBBIA, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.518
AS - Asia 4.275
EU - Europa 2.211
SA - Sud America 1.234
Continente sconosciuto - Info sul continente non disponibili 390
AF - Africa 103
OC - Oceania 2
Totale 16.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.347
SG - Singapore 1.790
IE - Irlanda 1.059
BR - Brasile 1.017
HK - Hong Kong 967
CN - Cina 478
IT - Italia 378
BD - Bangladesh 320
VN - Vietnam 319
DE - Germania 194
GB - Regno Unito 161
FR - Francia 111
TR - Turchia 101
CA - Canada 82
AR - Argentina 79
IN - India 77
MX - Messico 65
EC - Ecuador 45
FI - Finlandia 41
CH - Svizzera 37
ID - Indonesia 35
IQ - Iraq 35
NL - Olanda 35
ZA - Sudafrica 35
RU - Federazione Russa 30
SE - Svezia 28
PL - Polonia 27
MA - Marocco 22
CO - Colombia 21
ES - Italia 20
JP - Giappone 20
PY - Paraguay 18
VE - Venezuela 18
AT - Austria 17
UA - Ucraina 15
CZ - Repubblica Ceca 14
PK - Pakistan 14
KZ - Kazakistan 12
CL - Cile 10
LT - Lituania 10
SA - Arabia Saudita 10
TN - Tunisia 10
UZ - Uzbekistan 10
PH - Filippine 9
UY - Uruguay 9
BO - Bolivia 8
IL - Israele 8
JO - Giordania 8
KR - Corea 8
MY - Malesia 8
PE - Perù 8
AZ - Azerbaigian 7
EG - Egitto 7
NP - Nepal 7
DZ - Algeria 6
KE - Kenya 6
SN - Senegal 6
AL - Albania 5
CR - Costa Rica 5
LB - Libano 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BY - Bielorussia 4
TT - Trinidad e Tobago 4
CI - Costa d'Avorio 3
ET - Etiopia 3
HN - Honduras 3
KW - Kuwait 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
SV - El Salvador 3
AM - Armenia 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
IR - Iran 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
TH - Thailandia 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
MD - Moldavia 1
MR - Mauritania 1
Totale 16.335
Salva come PNG Salva come JPEG
Città #
Dallas 3.230
San Jose 1.235
Dublin 1.053
Hong Kong 961
Singapore 937
Ashburn 700
The Dalles 433
Santa Clara 402
Boardman 377
Chicago 363
Beijing 148
Ho Chi Minh City 127
London 99
São Paulo 94
New York 82
Los Angeles 80
Istanbul 77
Hanoi 67
Assago 56
Munich 54
Milan 50
Rio de Janeiro 39
Zurich 37
Helsinki 36
Frankfurt am Main 33
Naples 30
Mexico City 29
Montreal 27
Belo Horizonte 26
Prineville 26
Brooklyn 25
Buffalo 25
Amsterdam 24
Fort Worth 24
Chandler 23
Council Bluffs 21
Johannesburg 21
Warsaw 21
Boston 20
Quito 19
San Francisco 19
Brasília 18
Phoenix 18
Tokyo 18
Atlanta 17
Chennai 17
Curitiba 17
Haiphong 17
Springfield 17
Porto Alegre 16
Rome 16
Biên Hòa 15
Catania 15
Guayaquil 15
Hillsboro 15
Stockholm 15
Denver 14
Dhaka 14
Orem 14
Ottawa 14
Washington 14
Baghdad 13
Guarulhos 13
Seattle 12
Berlin 10
Goiânia 10
Tashkent 10
Bogotá 9
Brno 9
Charlotte 9
Hải Dương 9
New Delhi 9
Philadelphia 9
Shanghai 9
Toronto 9
Amman 8
Ankara 8
Asunción 8
Düsseldorf 8
Juiz de Fora 8
Manaus 8
Ninh Bình 8
Nuremberg 8
Palermo 8
Turin 8
Baku 7
Betim 7
Campinas 7
Caracas 7
Fortaleza 7
Guangzhou 7
Limburg an der Lahn 7
Manchester 7
Miami 7
Montevideo 7
Reston 7
Salvador 7
Santo André 7
Seoul 7
Thái Nguyên 7
Totale 11.791
Salva come PNG Salva come JPEG
Nome #
112. UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 308
Opsoclonus-myoclonus Syndrome in a Female Breast Cancer Patient: A Case Report and Literature Review 283
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 236
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: A phase II study 187
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin plus etoposide in extensive small-cell lung cancer (SCLC) patients The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial 123
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial 110
Is G8 geriatric assessment tool useful in managing elderly patients with metastatic pancreatic carcinoma? 105
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 98
Harmful Interference of Detoxifying Diets and Nutraceuticals with Adherence to Abemaciclib in Advanced Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Case Report 96
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 95
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group 95
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 94
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 91
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 91
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 90
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study 89
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer 89
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 88
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 88
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] 87
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 87
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group 86
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 86
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial 84
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 84
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 84
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations 83
Brain Metastasis in Endometrial Cancer: A Systematic Review 82
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 82
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. 81
5-Fluorouracil and Recombinant Alpha Interferon-2a in the Treatment of Advanced Colorectal Carcinoma: a Dose Optimization Study 81
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer 80
Combined Neuroendocrine Carcinoma and Hepatocellular Carcinoma of the Liver: Systematic Literature Review Suggests Implementing Biological Characterization to Optimize Therapeutic Strategy 79
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 79
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group 78
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma 78
Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients' Queries, Needs, Fears, and Actions Taken 77
Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis 77
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 77
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 77
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: A whatsapp messenger-based report from the Italian college of chief medical oncologists 75
Radiofrequency Thermoablation and Hypofractionated Radiotherapy Combined Treatment for Bone Metastases: A Retrospective Study 75
A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma 73
5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: a phase II randomized trial 73
Gastric metastasis from breast cancer 72
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patients 71
5-fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: Results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.) 71
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 68
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 68
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 66
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma 65
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 64
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 64
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 64
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study 64
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 64
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial 62
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety 62
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 62
TOWARD A NEW PROGNOSTIC-THERAPEUTIC INDEX IN GERIATRIC ONCOLOGY 62
Surviving Twenty Years to Bone and Liver Metastatic Breast Cancer: A Case Reported by Treating Oncologists and the Patient Herself 61
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603). 61
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer 60
Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients 59
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 59
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 59
Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study 59
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study 58
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 58
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer 57
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 57
In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1 56
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer 56
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 55
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy 55
Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group 55
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma 54
The Effects of the Macrocyclic Lactone Bryostatin-1 on Leukemic Cells in Vitro 54
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial 54
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome 54
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice 53
Cancer: New needs, new models. is it time for a community oncologist? another brick in the wall 53
Combination Chemotherapy with Cyclophosphamide, Doxorubicin and Vincristine in the Treatment of Stage III-IV Small-Cell Lung Cancer 53
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 53
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer 53
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial 53
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.) 53
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 53
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group 53
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study. 53
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 52
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 52
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 52
UN NUOVO INDICE PROGNOSTICO-TERAPEUTICO IN ONCOLOGIA GERIATRICA 51
Latissimus Dorsi Flap and Thoracodorsal Artery Perforator Flap with Immediate Fat Transfer (LIFT and TIFT): A Retrospective Study about Total Breast Reconstruction in High-Risk Patients 51
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB–IV non-small cell lung carcinoma: a prospective randomized study 51
Breast Cancer in Two Ex-Votos, A Millennia Apart: Patients' Hope and Faith Expressed Through the Centuries in Votive Offerings 51
Nutritional management of the patient with pancreatic cancer: From the diagnostic and therapeutic pathway to an integrated hospital-territory approach 50
Vinblastine and Interferon-Alpha-2a Regimen in the Treatment of Metastatic Renal Cell Carcinoma 50
A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma 50
Totale 7.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202226 0 0 0 0 0 0 0 5 2 7 2 10
2022/2023174 13 14 4 8 6 13 3 12 8 3 49 41
2023/2024970 39 84 66 77 138 104 158 62 50 52 40 100
2024/20255.303 423 366 528 100 512 470 409 278 757 561 565 334
2025/202610.013 642 2.102 1.788 836 320 395 1.122 734 756 565 473 280
2026/2027247 128 119 0 0 0 0 0 0 0 0 0 0
Totale 16.733